Washino, Satoshi
Shirotake, Suguru
Takeshita, Hideki
Inoue, Masaharu
Miura, Yuji
Hyodo, Yoji
Kagawa, Makoto
Izumi, Keita
Oyama, Masafumi
Kawakami, Satoru
Saito, Kazutaka
Matsuoka, Yoh
Taniuchi, Satsuki
Shintani, Ayumi
Miyagawa, Tomoaki
Article History
Received: 13 May 2023
Accepted: 21 August 2023
First Online: 2 September 2023
Declarations
:
: This study was approved by the institutional review board of each study institution and carried out according to the Declaration of Helsinki and its amendments. Informed consent was obtained from all patients via posters and/or websites using the opt-out method. Sugure Shirotake received lecture fees from Bristol Meyers Squibb and Ono Pharmaceutical. Yuji Miura received lecture fees from Takeda Pharmaceutical, Bristol Meyers Squibb and Eisai, and research grants from MSD and Ono Pharmaceutical. Kazutaka Saito received lecture fees from Takeda Pharmaceutical and Merck Biopharma. The other authors have no conflicts of interest to declare.